Cefotaxime and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Cefotaxime (cefotaxime sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Furosemide, and have Infection.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Cefotaxime. It is created by eHealthMe based on reports of 7,540 people who have side effects when taking Cefotaxime from the FDA, and is updated regularly.

What is Cefotaxime?

Cefotaxime has active ingredients of cefotaxime sodium. eHealthMe is studying from 7,559 Cefotaxime users. Check the latest studies of Cefotaxime.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 26, 2026

7,540 people reported to have side effects when taking Cefotaxime.
Among them, 84 people (1.11%) have Urinary tract infection.

Could Cefotaxime cause Urinary tract infection?

Among these 84 people:

How long have people been on Cefotaxime when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Cefotaxime? *

female: 59.49 %
male: 40.51 %

What is the age of people who have Urinary tract infection when taking Cefotaxime? *

What are other drugs people take besides Cefotaxime? *

What are other side effects people have besides Urinary tract infection? *

Fever: 27 people, 32.14%
Constipation: 19 people, 22.62%
Fatigue (feeling of tiredness): 19 people, 22.62%
Anaemia (lack of blood): 18 people, 21.43%
Dyspnea (difficult or laboured breathing): 15 people, 17.86%
Pain In Extremity: 13 people, 15.48%
High Blood Pressure: 10 people, 11.90%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 11.90%
Blood Creatinine Increased: 10 people, 11.90%
Abdominal Distension: 10 people, 11.90%

What are the existing conditions these people have? *

Infection: 14 people, 16.67%
Urination - Excessive Volume: 10 people, 11.90%
Depression: 10 people, 11.90%
Pain: 9 people, 10.71%
Sepsis (a severe blood infection that can lead to organ failure and death): 9 people, 10.71%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 8 people, 9.52%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 8 people, 9.52%
Abdominal Pain Upper: 7 people, 8.33%
Arrhythmias (irregular heartbeat): 7 people, 8.33%
Stress And Anxiety: 6 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefotaxime:

Cefotaxime (7,559 reports)

Browse all side effects of Cefotaxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Cefotaxime) and Cefotaxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.